Chardan Capital Maintains Buy on Notable Labs, Lowers Price Target to $5
Chardan Capital Maintains Buy on Notable Labs, Lowers Price Target to $5
Chardan Capital維持對著名實驗室的買入，將目標股價下調至5美元
Chardan Capital analyst Keay Nakae maintains Notable Labs (NASDAQ:NTBL) with a Buy and lowers the price target from $7 to $5.
Chardan Capital分析師Keay Nakae維持Notality Labs（納斯達克股票代碼：NTBL）的買入並將目標股價從7美元下調至5美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。